Weill Cornell Medicine-Qatar recently took part in the Autism Connect 2024 event, an annual initiative organized by the Child Development Center (CDC) for Special Needs in Doha, Qatar. This one-day community event aims to foster connections, provide education, and promote empowerment within the autism community. Dr. Ghizlane Bendriss, a neuroscientist and assistant professor of biology at WCM-Q, joined leading experts for a panel discussion on “Autism: Diagnosis, Intervention, and Advances in Research.” Dr. Bendriss teaches biology and neuroscience to pre-medical students at WCM-Q and leads various research projects focusing on the role of gut microbiota in neurological and neuropsychiatric conditions, including autism spectrum disorders.
During the panel discussion, Dr. Bendriss highlighted the connection between the gut-brain axis and autism. She discussed the growing evidence linking the loss of diversity in gut microbes to autism-like behavior and emphasized the importance of adopting a healthy lifestyle to regulate gut microbes and prevent the emergence of diseases. As a neurodevelopmental disorder that affects social interaction, communication, behavior, and learning, autism presents complex challenges that require continuous efforts to improve the lives of individuals with the condition. Dr. Bendriss expressed her gratitude for being invited to share her expertise at the event and praised the CDC for their dedication to building an educated and supportive autism community through initiatives like Autism Connect 2024.
Accompanying Dr. Bendriss at the event was Sama Ayoub, a second-year pre-medical student at WCM-Q. Together, they conducted a groundbreaking study comparing local Qatari yogurts to imported probiotic yogurts, focusing on characteristics such as resistance to acidity, probiotic content, antibiotic properties against pathogens, and antibiotic resistance. Ayoub served as the first author of a paper on this topic and collaborated with Dr. Bendriss on publishing a protocol for making highly probiotic-rich yogurt at home. Their research sheds light on the potential benefits of probiotic-rich foods in promoting gut health and overall well-being.
As a key figure in the field of neuroscience and biology, Dr. Bendriss’ research on the gut-brain axis and its implications for autism spectrum disorders contributes to the growing body of knowledge surrounding the complex interplay between gut health and neurological conditions. By focusing on the role of gut microbiota in autism, Dr. Bendriss and her team at WCM-Q are at the forefront of investigating innovative approaches to understanding and potentially treating autism and other neurodevelopmental disorders. Their participation in events like Autism Connect 2024 serves as a platform to share their findings, engage with the community, and raise awareness about the importance of gut health in overall well-being.
In conclusion, Weill Cornell Medicine-Qatar’s involvement in the Autism Connect 2024 event underscores their commitment to advancing knowledge and promoting awareness of autism spectrum disorders. Through their research on the gut-brain axis and collaborations with experts in the field, Dr. Bendriss and her team are making significant strides in understanding the underlying mechanisms of autism and exploring potential interventions for improving the lives of individuals affected by the condition. Their dedication to education, research, and community engagement continues to drive progress in the field of neurodevelopmental disorders, offering hope for a brighter future for individuals with autism.
